Altshuler Shaham’s iRadimed IRMD Stock Holding History

Altshuler Shaham’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.04K	Buy	+42	New	+$4.2K	﹤0.01%	317
2025 Q4	–	Sell	-60	Closed	-$4.27K	–	434
2025 Q3	$4.27K	Buy	+60	New	+$4K	﹤0.01%	282
2025 Q2	–	Sell	-72	Closed	-$3.78K	–	343
2025 Q1	$3.78K	Buy	+72	New	+$4.04K	﹤0.01%	258
2023 Q4	–	Sell	-475	Closed	-$21.1K	–	289
2023 Q3	$21.1K	Sell	475 -103	-18%	-$4.79K	﹤0.01%	245
2023 Q2	$27.6K	Buy	+578	New	+$26.1K	﹤0.01%	257
2022 Q2	–	Sell	-826	Closed	-$37K	–	504
2022 Q1	$37K	Buy	+826	New	+$38.2K	﹤0.01%	446
2019 Q1	–	Sell	-315	Closed	-$8K	–	323
2018 Q4	$8K	Buy	+315	New	+$8.46K	﹤0.01%	199

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Altshuler Shaham's IRMD Position: Q1 2026 in Review

Altshuler Shaham opened a new position in iRadimed (IRMD) in Q1 2026: 42 shares worth $4.04K. The stake represents ﹤0.01% of the portfolio and ranks #317 among its holdings. This is a return to the name: Altshuler Shaham previously reported a position in IRMD as recently as Q3 2025.

Altshuler Shaham first reported a position in IRMD in Q4 2018 and has held it in 7 quarters since. The position peaked at $37K in Q1 2022. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Altshuler Shaham held 42 shares of iRadimed worth $4.04K as of Q1 2026.
iRadimed was a new Altshuler Shaham position in Q1 2026.
iRadimed made up ﹤0.01% of Altshuler Shaham's portfolio in Q1 2026, its #317 holding.
Altshuler Shaham first reported a position in iRadimed in Q4 2018 and has held it in 7 quarters since.
Altshuler Shaham's iRadimed position peaked at $37K in Q1 2022.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Altshuler Shaham's 13F filing for Q1 2026, filed 18 May 2026.